Skip to main content

and
  1. No Access

    Article

    Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor

    Few studies have evaluated metabolic activity by 18F-FDG PET as a prognostic factor in advanced gastric cancer (AGC). We investigated its prognostic role in metastatic AGC.

    Jun Chul Park, Jae-Hoon Lee, Kungseok Cheoi in European Journal of Nuclear Medicine and M… (2012)